Broadmark Capital

Adam J. Fountain, Principal

Mr. Fountain's responsibilities at Broadmark include client sourcing and transaction management as well as activities related to Broadmark's merchant banking function: identifying and qualifying potential direct investments. Because of his background as a consultant to the life sciences industry, Mr. Fountain maintains relationships with numerous institutional investors in that field and typically leads those assignments and investment opportunities. Since joining Broadmark in 2003, Mr. Fountain has had a significant role in the following engagements: HipCricket, Omeros, Sound Pharmaceuticals, Zynex Medical, MediQuest Therapeutics, CardioMetrix and Shoreline.

Prior to joining Broadmark, Mr. Fountain was an Associate at L.E.K. Consulting, an international strategic consulting firm headquartered in London. While there, he worked primarily in the life sciences practice. Key projects included developing a product marketing and distribution strategy for an established European pharmaceutical company, formulating a product development and partnering strategy for a start-up biotechnology company, and preparing for the likely adoption of a new product in the medical device industry.

Mr. Fountain graduated with a B.A. in International Relations from Stanford University. He holds Series 7 and Series 63 FINRA registrations.

Email Adam at afountain@broadmark.com